(Q37642554)
Statements
1 reference
Targeting of memory T cells with alefacept in new-onset type 1 diabetes (T1DAL study): 12 month results of a randomised, double-blind, placebo-controlled phase 2 trial (English)
1 reference
Carla J Greenbaum
1 reference
Mark R Rigby
1 reference
Marc S Rendell
1 reference
Eric I Felner
1 reference
Jean M Dostou
1 reference
Stephen E Gitelman
1 reference
Chetanbabu M Patel
1 reference
Kurt J Griffin
1 reference
Peter A Gottlieb
1 reference
Nicole A Sherry
1 reference
Wayne V Moore
1 reference
Roshanak Monzavi
1 reference
Steven M Willi
1 reference
Philip Raskin
1 reference
Antoinette Moran
1 reference
William E Russell
1 reference
Ashley Pinckney
1 reference
Lynette Keyes-Elstein
1 reference
Michael Howell
1 reference
Sudeepta Aggarwal
1 reference
Noha Lim
1 reference
Deborah Phippard
1 reference
James McNamara
1 reference
Mario R Ehlers
1 reference
T1DAL Study Team
1 reference
23 September 2013
1 reference
1 reference
284-294
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference